İRFAN NUHOĞLU, Murat AYDIN, SÜLEYMAN TÜREDİ, Abdülkadir GÜNDÜZ, MURAT TOPBAŞ

Kene ile bulaşan hastalıklar

Parazitlerin neden olduğu hastalıklar önemli sağlık problemidir. Endoparazit ve ektoparaziter hastalıklar mevcuttur. Kenelerle bulaşan hastalıklar en sık görülen vektör kaynaklı hastalıklardır. Keneler bakteri, virüs spiroket, protozoa, nematod ve toksinler gibi patojenleri yayabilir ve böylece ektoparaziter kaynaklı hastalıklara sebep olurlar. Ülkemizde keneler için iklim koşulları, bitki örtüsü ve yüzey şekli bakımından uygun koşullar vardır. Bu makalemizde kenelerle bulaşan hastalıkları özetlemeye çalıştık.

Anahtar Kelimeler:

Rocky Dağı benekli ateşi, Lime hastalığı, Depreşen ateş, Erlikiyoz, Kene kaynaklı hastalıklar, Tularemi

Tick-borne diseases

Paraziter diseases are important medical problems.There are endoparasitic and ectoparasitic diseases. Tick-borne diseases are the most common vector-borne illnesses. Ticks can spread bacteria, viruses, spiroketia, protozoa, nemadot and toxins and by so they made ectoparasitic diseases. Our country has suitable conditions to continue biologic activity of ticks acording to seasons, plants and surface forms. In this article we have tried to summary tick-borne diseases.

Keywords:

Rocky Mountain Spotted Fever, Lyme Disease, Relapsing Fever, Ehrlichiosis, Tick-Borne Diseases, Tularemia,

PDF

___

1. Rajput ZI, Hu S, Chen W, Arıjo AG, Xiao C. Importance of ticks and their chemical and immunological control livestock. Journal of Zhejiang University. 2006; 7(11): 912-921.
2 Furman DP, Loomis EC. The ticks of California (Ascari: Ixodida). University of California Publications. Bulletin of the California Insect Survey. 1984; 25: 1-239.
3. Edlow JA, Danzl D, Halamka J, Pollack VC. Tick- Borne Diseases. www.eMedicine.com.
4. Snelson JT. Animal ectoparasites and disease vector causing major reduction in world food supplies. FAO Plant Prodection Bulleton. 1975;13: 103-114.
5. Barker SC, Murrell A. Systematics and evolution of ticks with alist of valid genus and species names. Parasitology. 2004; 129(7):15-36.
6. Klompen JSH, Black WC, Keirans JE, Oliver JH. Evolition of tiks. Annu Rev Entomol. 1996; 41(1):141-161.
7. Güler S, 198. Ankara ve civarındaki koyun ve keçilerde kış ixodidaeleri üzerine araştırmalar. U. Ü. Vet. Fak. Derg. 1 :54-55.
8. Güler S, Özer E, Erdoğmş SZ, Köroğlu E, Bektaş İ. Malatya ve bazı Güneydoğu Anadolu illerinde sığır, koyun ve keçilerde bulunan kene türleri. Doğa-Tr. J. Of Veterinary and animal Science. 1993; 17: 229-231.
9. Karaer Z, Yukarı BA, Aydın L. Türkiye keneleri ve vektörlükleri. Parazitolojide Andropod Hastalıkları ve Vektörler. İzmir, Türkiye. Parazitoloji Derneği Yayın No: 13, 1997, p. 363-434.
10. Hoogstraal H. The epidemiologymof tick borne Crimean-Congo hemorrhagic fever in Asia, europe and Africa. J Med Entomol 1979; 15: 307-417.
11. Watts DM, Ksiazek TG, Linthicum KJ, Hoogstraal H. Crimean-Congo hemorrhagic fever. In:Monath TP, ed. The arboviruses: epidemiology and ecology, volume 2. Boca Raton, FL, USA:CRC Pres, 1988, p. 177-260.
12. Ergönül O, Celikbaş A, Dokuzoğuz B, Eren S, Baykam N, Esener H. The characteristicks of Crimean-Congo hemorhagic fever in a recent outbreak in Turkey and the impact of oral ribavirin therapy. Clin Infect Dis. 2004; 39: 285-89.
13. Ergönül Ö. Crimean-Congo haemorrhagic fever. The Lancet. 2006; 6: 203-214.
14. Kartı SS, Odabaşı S, Korten V, et al. Crimean- Congo hemorrhagic fever in Turkey. Emerg Infect Dis. 2004; 19: 1379-84.
15. Ozkurt Z, Kiki I, Erol S, et al. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J Infect. 2006; 52: 207-15.
16. Türkiye’de KKKA yayılım haritası. www.tvhb.org.tr 17. Whitehause CA. Crimean-Congo hemorrhagic fever. Antivir Res 2004; 64: 145-60.
18. Swanepoel R, Gill DE, Shepherd AJ, et al. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis. 1989; 11: 794-800.
19. Smego RA, Sarwari AR, Siddiqui AR. Crimean- Congo hemorrhagic fever: Prevention and control limitations in a resource poor country. Clin Infect Dis. 2004; 38: 1731-35.
20. Swanepoel R, Shepherd AJ, Leman PA, et al. Epidemiologic and clinical features of Crimean- Congo hemorrhagic fever in southern Africa. Am J Trop Med Hyg. 1987;36: 120-32.
21. Ergönül O, Celikbaş A, Baykam N, Eren S, Esener H, Dokuzoğuz B. Analysis of the mortality among the patients with Crimean-Congo hemorrhagic fever virus infection. Clin Microbiol Infect (in press).
22. Burt FJ, Leman PA, Abott JC, Swanepoel R. Serodiagnosis of Crimean-Congo haemorhagic fever. Epidemiol Infect. 1994;113: 551-62.
23. Schwarz TF, Nsanze H, Longson M, et al. Polymerase chain reaction for diagnosis and identification of distinct variants of Crimean- Congo hemorrhagic fever virus in the United Arab Emirates. Am J Trop Med Hyg. 1996; 55: 190-96.
24. Ahephered AJ, Swanepoel R, Leman PA. Antibody response in Crimean-Congo hemorrhagic fever. Rev Infect Dis. 1989; 11: 801-806.
25. Knowles SR, Phillips EJ, Dresser I, Matukas I. Common adverse events associated with the use of ribavirin for severe acte respiratory syndrome in Canada. Clin Infect Dis. 2003; 37: 1139-42.
26. Chiou HE, LiuCI, Buttrey MJ, et al. Advere effects of ribavirin and outcome in severe acute respiratory syndrome: experience in two medical centers. Chest. 2005; 128: 263-72.
27. Ticks. www.co.franklin.oh
28. Walker DH, Raoult D. Rickettsia rickettsii and other spotted fever group rickettsiae (Rocky Mountain spotted fever and other spotted fevers). In: Mandel GL, Douglas RG, Bennett JE Dolin R, eds. Mandell, Douglas and Bennett’s Principles and practice of infectious diseases. 5th ed. Philadelphia. Churchill Livingstone, 2000, p.2393-402.
29. Walker DH. Tick-transmitted infectious diseases in the United States. Annu Rev public Health 1998; 19: 237-69.
30. Tick information. www.cdc.gov. 31. Spach DH, Liles WC, Campbell GL, Quick RE, Anderson DE Jr, Fritsche TR: Tick-borne diseases in the United States. N Engl J Med. 1993; 329: 936-47.
32. Thorner AR, Walker DH, Petri WA Jr. Rocky mountain spotted fever. Clin Ifect Dis. 1998; 27:1353-60.
33. Steeve AC. Lyme borreliosis. In: Kasper DL, Harrison TR: Harrison’s Manual of medicine.16th ed. New York: McGraw-Hill, 2005, p. 995-9.
34. Tick-borne diseases. www.aafp.org. 35. Centers for Disease Control and Prevention. Rocky Mountain spotted fever. Accessed online April 11 2005. at: www.cdc.gov.
36. Taege AJ. Tick trouble: overview of tick-borne diseases. Cleve Clin J Med. 2000; 67: 245-9.
37. Ticks. www.health.nsw.gov.au. 38. Centers for disease control and prevention. Lyme disease-United States, 1999. MMWR morb Mortal Wkly Rep. 2001; 50: 181-85.
39. Steere AC, Bartenhagen NH, Craft JE, Hutchinson GJ, Newman JH, Rahn DW, et al. The early clinical manifestation of Lyme disease. Ann Intern Med. 1983; 99: 76-82.
40. Beers MH, Berkow R. The Merck manual of diagnosis and therapy. 17th ed. Merck Research Laboratories. Whitehause Station, n.J, 1999.
41. Treatment of Lyme disease. Med Lett Drugs Ther. 2000; 42: 37-9.
42. Deborah SF. Prevent Tick bites: Prevent Lyme Disease. Rutgers Coperative extensions. 1992,FS637.
43. Belman AL. Tick-borne diseases. Semin Pediatr Neurol. 1999; 6: 249-66.
44. Fritz CL, Glaser CA. Erlichsis. Infect Dis Clin North Am. 1998; 12: 123-36.
45. Cox SK, Everett ED. Tularemia, an analysis of 25 cases. Mo Med 1981; 78: 70-4.
46. Bratton RL; Corey GR. Tick-Borne Diseases.www.aafp.org.
47. Kjemtrup AM, Conrad PA. Human babesiosis: an emerging tick-borne disease. Int J Parasitology. 2000; 30: 1323-1337.